Presynaptic A1-purinoceptor-mediated inhibitory effects of adenosine and its stable analogues on the mouse hemidiaphragm preparation

O. Nagano, F. F. Foldes, H. Nakatsuka, D. Reich, Y. Ohta, B. Sperlágh, E. Vízi

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

The effect of adenosine or its stable analogues (2-chloroadenosine, CADO; 5'-N-ethylcarboxamidoadenosine, NECA; and N6-cyclopentyladenosine, CPA) on the release of [3H]-acetylcholine ([3H]-ACh), and on the development of force of contraction evoked by electrical stimulation of the nerve, were studied in the mouse phrenic nerve-hemidiaphragm preparation. Evidence was obtained that the release of ACh is subject to presynaptic modulation through presynaptic A1 (P1)-purinoceptors. Adenosine or its stable analogues (CADO, NECA, CPA) inhibited, in a concentration-dependent manner, both the release of ACh and the force of the indirectly elicited contraction of hemidiaphragm preparation, provided in the latter case that the margin of safety was reduced by (+)-tubocurarine or magnesium. The order of potency in reducing ACh release was CPA > NECA > CADO > adenosine with IC50 values of 0.08 ± 0.01, 0.74 ± 0.05, 9.05 ± 0.20, and 410.2+ 42.5 μmol/l, respectively. The order of potency in reducing twitch tension was CPA > NECA > CADO > adenosine with IC50 values of 0.11 ± 0.02, 0.48 ± 0.03, 2.07 ± 0.49, and 240.4 ± 20.0 μmol/l, respectively. 8-Phenyltheophylline (8-PT) antagonized the inhibitory effects of the adenosine receptor agonists on ACh release and twitch tension. The finding that -log K(B) and pA2 values estimated for 8-PT on ACh release and twitch tension were similar when adenosine or its stable analogues were applied as agonists suggest (i) that the motor nerve terminals are equipped with inhibitory P1-purinoceptors and (ii) that twitch responses of the partially curarized phrenic nerve-hemidiaphragm preparation to electrical stimulation can be used for studying the presynaptic inhibitory effect of P1-purinoceptor agonists. The findings that 8-PT and 8-cyclopentyl-1,3-dipropylxanthine (DPCPX), a selective A1-purinoceptor antagonist, enhanced the release of [3H]-ACh in response to nerve stimulation and DPCPX antagonized the inhibitory effect of CADO on twitch tension (pA2 = 10.77 ± 1.34) indicate that these receptors are of A1-subtype. Dipyridamole, an adenosine uptake blocker, reduced the release of [3H]-ACh, and reinforced the effect of adenosine, but did not affect responses to adenosine analogues not taken up by the tissue. It is concluded that the cholinergic axon terminals located at the neuromuscular junction are equipped with inhibitory A1-purinoceptors. Endogenous adenosine derived either from ATP or directly from the muscle or nerve terminals might thus activate these receptors to inhibit ACh release and thereby presynaptically influences chemical neurotransmission at the neuromuscular junction.

Original languageEnglish
Pages (from-to)197-202
Number of pages6
JournalNaunyn-Schmiedeberg's Archives of Pharmacology
Volume346
Issue number2
Publication statusPublished - 1992

Fingerprint

Purinergic Receptors
Adenosine
Adenosine-5'-(N-ethylcarboxamide)
Purinergic P1 Receptor Agonists
Phrenic Nerve
Purinergic P1 Receptors
Neuromuscular Junction
Electric Stimulation
Inhibitory Concentration 50
Purinergic Antagonists
2-Chloroadenosine
Tubocurarine
Dipyridamole
Presynaptic Terminals
Synaptic Transmission
Magnesium
Cholinergic Agents
Acetylcholine
Adenosine Triphosphate
Safety

Keywords

  • [H]-acetylcholine release
  • A(P)-purinoceptor
  • adenosine analogues
  • hemidiaphragm
  • twitch contraction

ASJC Scopus subject areas

  • Pharmacology

Cite this

Presynaptic A1-purinoceptor-mediated inhibitory effects of adenosine and its stable analogues on the mouse hemidiaphragm preparation. / Nagano, O.; Foldes, F. F.; Nakatsuka, H.; Reich, D.; Ohta, Y.; Sperlágh, B.; Vízi, E.

In: Naunyn-Schmiedeberg's Archives of Pharmacology, Vol. 346, No. 2, 1992, p. 197-202.

Research output: Contribution to journalArticle

@article{49ee0ff353744388a3158dfa2c1061de,
title = "Presynaptic A1-purinoceptor-mediated inhibitory effects of adenosine and its stable analogues on the mouse hemidiaphragm preparation",
abstract = "The effect of adenosine or its stable analogues (2-chloroadenosine, CADO; 5'-N-ethylcarboxamidoadenosine, NECA; and N6-cyclopentyladenosine, CPA) on the release of [3H]-acetylcholine ([3H]-ACh), and on the development of force of contraction evoked by electrical stimulation of the nerve, were studied in the mouse phrenic nerve-hemidiaphragm preparation. Evidence was obtained that the release of ACh is subject to presynaptic modulation through presynaptic A1 (P1)-purinoceptors. Adenosine or its stable analogues (CADO, NECA, CPA) inhibited, in a concentration-dependent manner, both the release of ACh and the force of the indirectly elicited contraction of hemidiaphragm preparation, provided in the latter case that the margin of safety was reduced by (+)-tubocurarine or magnesium. The order of potency in reducing ACh release was CPA > NECA > CADO > adenosine with IC50 values of 0.08 ± 0.01, 0.74 ± 0.05, 9.05 ± 0.20, and 410.2+ 42.5 μmol/l, respectively. The order of potency in reducing twitch tension was CPA > NECA > CADO > adenosine with IC50 values of 0.11 ± 0.02, 0.48 ± 0.03, 2.07 ± 0.49, and 240.4 ± 20.0 μmol/l, respectively. 8-Phenyltheophylline (8-PT) antagonized the inhibitory effects of the adenosine receptor agonists on ACh release and twitch tension. The finding that -log K(B) and pA2 values estimated for 8-PT on ACh release and twitch tension were similar when adenosine or its stable analogues were applied as agonists suggest (i) that the motor nerve terminals are equipped with inhibitory P1-purinoceptors and (ii) that twitch responses of the partially curarized phrenic nerve-hemidiaphragm preparation to electrical stimulation can be used for studying the presynaptic inhibitory effect of P1-purinoceptor agonists. The findings that 8-PT and 8-cyclopentyl-1,3-dipropylxanthine (DPCPX), a selective A1-purinoceptor antagonist, enhanced the release of [3H]-ACh in response to nerve stimulation and DPCPX antagonized the inhibitory effect of CADO on twitch tension (pA2 = 10.77 ± 1.34) indicate that these receptors are of A1-subtype. Dipyridamole, an adenosine uptake blocker, reduced the release of [3H]-ACh, and reinforced the effect of adenosine, but did not affect responses to adenosine analogues not taken up by the tissue. It is concluded that the cholinergic axon terminals located at the neuromuscular junction are equipped with inhibitory A1-purinoceptors. Endogenous adenosine derived either from ATP or directly from the muscle or nerve terminals might thus activate these receptors to inhibit ACh release and thereby presynaptically influences chemical neurotransmission at the neuromuscular junction.",
keywords = "[H]-acetylcholine release, A(P)-purinoceptor, adenosine analogues, hemidiaphragm, twitch contraction",
author = "O. Nagano and Foldes, {F. F.} and H. Nakatsuka and D. Reich and Y. Ohta and B. Sperl{\'a}gh and E. V{\'i}zi",
year = "1992",
language = "English",
volume = "346",
pages = "197--202",
journal = "Naunyn-Schmiedeberg's Archives of Pharmacology",
issn = "0028-1298",
publisher = "Springer Verlag",
number = "2",

}

TY - JOUR

T1 - Presynaptic A1-purinoceptor-mediated inhibitory effects of adenosine and its stable analogues on the mouse hemidiaphragm preparation

AU - Nagano, O.

AU - Foldes, F. F.

AU - Nakatsuka, H.

AU - Reich, D.

AU - Ohta, Y.

AU - Sperlágh, B.

AU - Vízi, E.

PY - 1992

Y1 - 1992

N2 - The effect of adenosine or its stable analogues (2-chloroadenosine, CADO; 5'-N-ethylcarboxamidoadenosine, NECA; and N6-cyclopentyladenosine, CPA) on the release of [3H]-acetylcholine ([3H]-ACh), and on the development of force of contraction evoked by electrical stimulation of the nerve, were studied in the mouse phrenic nerve-hemidiaphragm preparation. Evidence was obtained that the release of ACh is subject to presynaptic modulation through presynaptic A1 (P1)-purinoceptors. Adenosine or its stable analogues (CADO, NECA, CPA) inhibited, in a concentration-dependent manner, both the release of ACh and the force of the indirectly elicited contraction of hemidiaphragm preparation, provided in the latter case that the margin of safety was reduced by (+)-tubocurarine or magnesium. The order of potency in reducing ACh release was CPA > NECA > CADO > adenosine with IC50 values of 0.08 ± 0.01, 0.74 ± 0.05, 9.05 ± 0.20, and 410.2+ 42.5 μmol/l, respectively. The order of potency in reducing twitch tension was CPA > NECA > CADO > adenosine with IC50 values of 0.11 ± 0.02, 0.48 ± 0.03, 2.07 ± 0.49, and 240.4 ± 20.0 μmol/l, respectively. 8-Phenyltheophylline (8-PT) antagonized the inhibitory effects of the adenosine receptor agonists on ACh release and twitch tension. The finding that -log K(B) and pA2 values estimated for 8-PT on ACh release and twitch tension were similar when adenosine or its stable analogues were applied as agonists suggest (i) that the motor nerve terminals are equipped with inhibitory P1-purinoceptors and (ii) that twitch responses of the partially curarized phrenic nerve-hemidiaphragm preparation to electrical stimulation can be used for studying the presynaptic inhibitory effect of P1-purinoceptor agonists. The findings that 8-PT and 8-cyclopentyl-1,3-dipropylxanthine (DPCPX), a selective A1-purinoceptor antagonist, enhanced the release of [3H]-ACh in response to nerve stimulation and DPCPX antagonized the inhibitory effect of CADO on twitch tension (pA2 = 10.77 ± 1.34) indicate that these receptors are of A1-subtype. Dipyridamole, an adenosine uptake blocker, reduced the release of [3H]-ACh, and reinforced the effect of adenosine, but did not affect responses to adenosine analogues not taken up by the tissue. It is concluded that the cholinergic axon terminals located at the neuromuscular junction are equipped with inhibitory A1-purinoceptors. Endogenous adenosine derived either from ATP or directly from the muscle or nerve terminals might thus activate these receptors to inhibit ACh release and thereby presynaptically influences chemical neurotransmission at the neuromuscular junction.

AB - The effect of adenosine or its stable analogues (2-chloroadenosine, CADO; 5'-N-ethylcarboxamidoadenosine, NECA; and N6-cyclopentyladenosine, CPA) on the release of [3H]-acetylcholine ([3H]-ACh), and on the development of force of contraction evoked by electrical stimulation of the nerve, were studied in the mouse phrenic nerve-hemidiaphragm preparation. Evidence was obtained that the release of ACh is subject to presynaptic modulation through presynaptic A1 (P1)-purinoceptors. Adenosine or its stable analogues (CADO, NECA, CPA) inhibited, in a concentration-dependent manner, both the release of ACh and the force of the indirectly elicited contraction of hemidiaphragm preparation, provided in the latter case that the margin of safety was reduced by (+)-tubocurarine or magnesium. The order of potency in reducing ACh release was CPA > NECA > CADO > adenosine with IC50 values of 0.08 ± 0.01, 0.74 ± 0.05, 9.05 ± 0.20, and 410.2+ 42.5 μmol/l, respectively. The order of potency in reducing twitch tension was CPA > NECA > CADO > adenosine with IC50 values of 0.11 ± 0.02, 0.48 ± 0.03, 2.07 ± 0.49, and 240.4 ± 20.0 μmol/l, respectively. 8-Phenyltheophylline (8-PT) antagonized the inhibitory effects of the adenosine receptor agonists on ACh release and twitch tension. The finding that -log K(B) and pA2 values estimated for 8-PT on ACh release and twitch tension were similar when adenosine or its stable analogues were applied as agonists suggest (i) that the motor nerve terminals are equipped with inhibitory P1-purinoceptors and (ii) that twitch responses of the partially curarized phrenic nerve-hemidiaphragm preparation to electrical stimulation can be used for studying the presynaptic inhibitory effect of P1-purinoceptor agonists. The findings that 8-PT and 8-cyclopentyl-1,3-dipropylxanthine (DPCPX), a selective A1-purinoceptor antagonist, enhanced the release of [3H]-ACh in response to nerve stimulation and DPCPX antagonized the inhibitory effect of CADO on twitch tension (pA2 = 10.77 ± 1.34) indicate that these receptors are of A1-subtype. Dipyridamole, an adenosine uptake blocker, reduced the release of [3H]-ACh, and reinforced the effect of adenosine, but did not affect responses to adenosine analogues not taken up by the tissue. It is concluded that the cholinergic axon terminals located at the neuromuscular junction are equipped with inhibitory A1-purinoceptors. Endogenous adenosine derived either from ATP or directly from the muscle or nerve terminals might thus activate these receptors to inhibit ACh release and thereby presynaptically influences chemical neurotransmission at the neuromuscular junction.

KW - [H]-acetylcholine release

KW - A(P)-purinoceptor

KW - adenosine analogues

KW - hemidiaphragm

KW - twitch contraction

UR - http://www.scopus.com/inward/record.url?scp=0026616835&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026616835&partnerID=8YFLogxK

M3 - Article

C2 - 1333058

AN - SCOPUS:0026616835

VL - 346

SP - 197

EP - 202

JO - Naunyn-Schmiedeberg's Archives of Pharmacology

JF - Naunyn-Schmiedeberg's Archives of Pharmacology

SN - 0028-1298

IS - 2

ER -